Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.

被引：0
|
作者：
Kocher, Florian
Seeber, Andreas
Weiss, Lukas
Romeder, Franz
Szkandera, Joanna
Kuhr, Thomas
Kostner, Susanne
Pichler, Petra
Jaeger, Thomas
Greil, Richard
Brodowicz, Thomas
机构：
[1] Med Univ Innsbruck, Dept Internal Med Hematol & Oncol 5, Innsbruck, Austria
[2] Dept Internal Med V Hematol & Oncol, Innsbruck, Austria
[3] Paracelsus Med Univ, Salzburg Canc Res Inst, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria
[4] Hosp Barmherzige Schwestern Linz, Internal Med Dept Med Oncol Hematol & Gastroenter, Linz, Austria
[5] Med Univ Graz, Div Clin Oncol, Graz, Austria
[6] Hosp Wels Grieskirchen, Dept Internal Med 4, Wels, Austria
[7] Hosp Schwaz, Dept Internal Med, Schwaz, Austria
[8] Univ Klinikum St Polten, St Polten, Austria
[9] Acad Teaching Hosp Feldkirch, Internal Med Med Oncol Hematol Gastroenterol & Rh, Feldkirch, Austria
[10] Paracelsus Med Univ, Ctr Oncol, Dept Internal Med Hematol Med Oncol Hemostaseol I, Salzburg, Austria
[11] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22550
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study
    Zengjun Liu
    Jing Xu
    Mengyao Liu
    Wenyu Hu
    Ni Xu
    Dongyuan Zhu
    Scientific Reports, 13
  • [22] Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
    Ahmet Bilici
    Sinan Koca
    Mustafa Karaagac
    Sabin Goktas Aydin
    Emrah Eraslan
    Muhammed Ali Kaplan
    Birol Ocak
    Sema Sezgin Goksu
    Semra Paydas
    Fahri Akgul
    Sumeyye Derin
    Yakup Ergun
    Emre Yekeduz
    Cihan Erol
    Deniz Tataroglu Ozyukseler
    Atike Gokcen Demiray
    Mustafa Karaca
    Zeynep Gulsum Guc
    Serkan Menekse
    Havva Yesil Cinkir
    Ozge Gumusay
    Abdullah Sakin
    Ozlem Ozkul
    Hacer Demir
    Dilek Erdem
    Mehmet Besiroglu
    Olcun Umit Unal
    Ramazan Acar
    Lokman Koral
    Suleyman Sahin
    Teoman Sakalar
    Aykut Bahceci
    Ahmet Ozveren
    Ulug Mutlu Gunaydin
    Mehmet Metin Seker
    Veli Sunar
    Pinar Dal
    Mehmet Artac
    Serdar Turhal
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8243 - 8253
  • [23] Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
    Bilici, Ahmet
    Koca, Sinan
    Karaagac, Mustafa
    Aydin, Sabin Goktas
    Eraslan, Emrah
    Kaplan, Muhammed Ali
    Ocak, Birol
    Goksu, Sema Sezgin
    Paydas, Semra
    Akgul, Fahri
    Derin, Sumeyye
    Ergun, Yakup
    Yekeduz, Emre
    Erol, Cihan
    Ozyukseler, Deniz Tataroglu
    Demiray, Atike Gokcen
    Karaca, Mustafa
    Guc, Zeynep Gulsum
    Menekse, Serkan
    Cinkir, Havva Yesil
    Gumusay, Ozge
    Sakin, Abdullah
    Ozkul, Ozlem
    Demir, Hacer
    Erdem, Dilek
    Besiroglu, Mehmet
    Unal, Olcun Umit
    Acar, Ramazan
    Koral, Lokman
    Sahin, Suleyman
    Sakalar, Teoman
    Bahceci, Aykut
    Ozveren, Ahmet
    Gunaydin, Ulug Mutlu
    Seker, Mehmet Metin
    Sunar, Veli
    Dal, Pinar
    Artac, Mehmet
    Turhal, Serdar
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8243 - 8253
  • [24] COST-EFFECTIVENESS OF OLARATUMAB IN COMBINATION WITH DOXORUBICIN FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC SOFT TISSUE SARCOMA IN THE UNITED STATES
    Zuluaga, S.
    Hess, L. M.
    Wolowacz, S.
    Dyachkova, Y.
    Hawe, E.
    Vickers, A. D.
    Kaye, J. A.
    Bertwistle, D. S.
    VALUE IN HEALTH, 2017, 20 (05) : A108 - A108
  • [25] Efficacy and safety of eribulin in the treatment of advanced adult soft tissue sarcoma (STS): First real-world data in Chinese population.
    Guo, Xi
    Zhou, Yuhong
    Zhuang, Rongyuan
    You, Yang
    Zhang, Chenlu
    Wang, Zhiming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma
    Schoffski, Patrick
    Bahleda, Rastislav
    Wagner, Andrew J.
    Burgess, Melissa A.
    Junker, Niels
    Chisamore, Michael
    Peterson, Patrick
    Szpurka, Anna M.
    Ceccarelli, Matteo
    Tap, William D.
    CLINICAL CANCER RESEARCH, 2023, 29 (17) : 3320 - 3328
  • [27] Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data
    Sotes, Ibon Gurruchaga
    Gomez-Mateo, M. Carmen
    Izquierdo, Maria Eugenia Ortega
    Martinez-Trufero, Javier
    CANCERS, 2024, 16 (02)
  • [28] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN BRAZIL
    Melo, A. C.
    Santi, P. X.
    Nunes, D. L.
    Aleixo, S. B.
    Martins, C. L.
    de Silva, A. V. T.
    Fernandez, F. L. C.
    Beato, P. M. M.
    Guimaraes, C. M.
    Oliveira, R. W.
    Silva Julian, G.
    Souza, H.
    Gatti de Menezes, F.
    Novick, D.
    VALUE IN HEALTH, 2019, 22 : S534 - S535
  • [29] Trabectedin in soft-tissue sarcoma patients in Italy: Analysis of real-world data from a national registry
    Vincenzi, B.
    Celant, S.
    Di Segni, S.
    Olimpieri, P. P.
    Comandone, A.
    Napolitano, A.
    Sanfilippo, R.
    Russo, P.
    Casali, P. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1123 - S1123
  • [30] Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
    Chung Ryul Oh
    Jung Yong Hong
    Jee Hung Kim
    Ji Sung Lee
    Hyo Song Kim
    Tae Won Kim
    Jin-Hee Ahn
    Jeong Eun Kim
    Targeted Oncology, 2020, 15 : 485 - 493
12345